Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-13 @ 10:59 PM
Study NCT ID:
NCT02559856
Status:
COMPLETED
Last Update Posted:
2025-11-17
First Post:
2015-09-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study
Sponsor:
Ottawa Hospital Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-21
First Submit QC Date:
None
Study First Post Date:
2015-09-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-17
Last Update Post Date Type:
ESTIMATED